Categories

A sample text widget

Etiam pulvinar consectetur dolor sed malesuada. Ut convallis euismod dolor nec pretium. Nunc ut tristique massa.

Nam sodales mi vitae dolor ullamcorper et vulputate enim accumsan. Morbi orci magna, tincidunt vitae molestie nec, molestie at mi. Nulla nulla lorem, suscipit in posuere in, interdum non magna.

Turning Failure into Success

Now, if reading that, if you were expecting to hear of some highly motivational experience, move along, nothing to see here…

I tend to remember things I read or see if I’m interested in what is going on. So I end up with a bunch of trivial facts about this or that floating around in my head and then I’ll see something else that my brain decides is linked to one of those things and they all pop to the forefront.  Sometimes things pop to the front and it takes me a while to figure out why I linked them together, let alone be able to rationally explain it to someone else.

Where I’m going with this is that last week I read an article that reminded me of one I had read several years ago but hadn’t heard of since. So what this is actually about all those studies that “could” do this or that for diabetes treatment but seem to never be heard about again.   What happens to these “things” we “hear” about?

Did it turn out that the original findings couldn’t be replicated?  Rats were happy about it, but humans turned a funny shade of green and exploded when they tried it?

  Or do they get quietly shelved, purchased by some large company so there is not a threat to thier revenue stream?  Happens all the time in the tech sector.  < Removes tinfoil hat >

I guess for me, I find it just as informative that further investigation failed to produce favorable results.  Does the media just not emphasize the failures because the “could cure” byline is so much more attention grabbing?

By coincidence, Amy over at DiabetesMine today posted a very interesting article today: An Open National Data Registry for Type 1 Diabetes.  Her closing paragraph caught my attention

What would really be impactful, some of us at the ADA conference mused, would be if pharma companies are willing to share their research data in an open environment like the T1D Exchange registry. A big boost for unbiased research? One can only hope.

I too share that hope.  Not only pharma, but other research institutions as well, university’s and the like. The faster information can be found and shared; the faster the research will progress. 

Just because a research project “failed” doesn’t mean it was worthless.  It means we learned something unexpected.

Thanks for stopping by
Scott

Todays snarky comment: With all due respect, just because you don’t like my answer, doesn’t make it the wrong one.

  • Scott K. Johnson

    You are so right about this. Even with we learn that we don’t need to spend any more energy down a certain path, that is useful right?